SENSEX NIFTY

Wockhardt Pharma

Sep 24, 2015 at 10:35 | Source: CNBC-TV18
Watch the interview of Hemant Thukral of Aditya Birla Money with Latha Venkatesh and Sonia Shenoy on CNBC-TV18, in which he shared his reading and outlook on market and specific stocks.
Sep 16, 2015 at 08:51 | Source: Moneycontrol.com
Meghana V Malkan of malkansview.com is of the view that one may buy Ajanta Pharma with a target of Rs 1555.
Sep 14, 2015 at 10:50 | Source: CNBC-TV18
According to Hemant Thukral of Aditya Birla Money, Wockhardt is a good traders pick and feels that it may test Rs 1550.
Sep 10, 2015 at 07:49 | Source: CNBC-TV18
Manav Chopra of Networth Stock Broking advises buying LIC Housing Finance with a target of Rs 450.
Sep 08, 2015 at 07:57 | Source: CNBC-TV18
Sharmila Joshi, Market Expert advises buying KS Micro with a target of Rs 450.
Sep 03, 2015 at 08:11 | Source: Reuters
In trading so far this year, Lupin Ltd has climbed 32 percent, Dr. Reddy's 31 percent, Glenmark Pharmaceuticals 42 percent and Wockhardt 29 percent.
Aug 31, 2015 at 09:04 | Source: CNBC-TV18
Glenmark Pharma, Zee Entertainment, followed by Airtel and Idea to lead the top 10 stock list.
Aug 31, 2015 at 08:17 | Source: CNBC-TV18
ITC | Sun Pharma | Wockhardt | GMR Infra | ONGC | Mahindra and Mahindra | Oil India | Novartis India | IDBI Bank | Godrej Consumer | UltraTech Cement | Bharti Airtel | Idea Cellular and Astec Life are stocks, which are in the news today.
Aug 30, 2015 at 13:53 | Source: PTI
According to a notification issued by the US Food and Drug Administration, Sun Pharma's recall was initiated last month under Class-III classification which was as 'a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences'.
Aug 27, 2015 at 10:25 | Source: CNBC-TV18
Sudarshan Sukhani of s2analytics.com recommends buying Divis Laboratories and Wockhardt and adding Aurobindo Pharma.
Messages on Wockhardt Pharma »

bns678

New Member

0 Follower

Wockhardt  

Wockhardt pharma has so many new drungs in pipeline and also completed preclinical trials. As u aware they recently got continuation certifiacte from MHRA _UK for API

2.27 PM Sep 30th

shiv_analys
t

Platinum Member

513 Followers

Wockhardt  

Wockhardt Pharma-Sell with target of 900-880-865 for intraday-news of sfda was fake as per sorces of market-there is some gang of speculators active in which media persons also involved

10.28 AM Sep 19th

raghav2009

Silver Member

8 Followers

Wockhardt  

get ready for new high in wockhardt pharma.

3.18 PM Sep 16th

yksaraswat

Gold Member

349 Followers

Nectar Life  

Result on valentines day 14 feb. with wockhardt pharma.We all hopes good turn around story on the board.........yogesh

10.25 AM Feb 8th 2013

Reach4Stars

Silver Member

34 Followers

Marksans Pharma  

Within Pharma stocks, 2013 will belong to Marksans Pharma. 2012 was year of Wockhardt Pharma. Turnaround story for Marksans very similar to Wockhardt. We all saw Wockhardt moving from Rs 100 to Rs Rs 1500 . Story in Marksans will be even better. Just buy buy.... use every dip to accumulate. First

11.57 AM Dec 14th 2012

VIPPY

Gold Member

0 Follower

Wockhardt  

pls advice strength of KPIT cummins and Wockhardt pharma ????

10.09 AM Dec 13th 2012

VIPPY

Gold Member

0 Follower

KPIT Cummins  

pls advice strength of KPIT cummins and Wockhardt pharma ????

10.08 AM Dec 13th 2012

RAJ BHATIA

Platinum Member

368 Followers

Aurobindo Pharm  

IF U HAVE ENTERED IN WOCKHARDT PHARMA AT LOVER LEVELS U SHOULD BOOK PROFIT,BUT IN AUROBINDO AND DISHMAN I THINK LOT OF UP MOVE IS STILL PENDING.NOW IT IS UP TO U.

1.23 PM Nov 20th 2012

Other Market Topics  

Wockhardt Pharma which has debt to equity ratio of above 1, has price to Book value of 152.. Some companies have Price to Book value of 5-10 in the same segment.

1.41 PM Nov 9th 2012

Other Market Topics  

Wockhardt Pharma which has debt to equity ratio of above 1% has price to Book value of 152.. Some companies have Price to Book value of 5-10 in the same segment.

1.41 PM Nov 9th 2012

News across the web »
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.